Dear Editor, we would like to discuss on "Clinical and CT features in pediatric patients with COVID‐19 infection: different points from adults.[^1^](#ppul24737-bib-0001){ref-type="ref"}" Xia et al[^1^](#ppul24737-bib-0001){ref-type="ref"} concluded that "procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults.[^1^](#ppul24737-bib-0001){ref-type="ref"}" We would like to share observations from our country, Thailand, which is the second country that the disease has existed since January 2020.[^2^](#ppul24737-bib-0002){ref-type="ref"} In our country, there are already 48 patients with COVID‐19. Two of these cases are pediatric patients (3‐year‐old female and 7‐year‐old male). Comparing to the total number of infected cases, the percentage of pediatric cases might be high. Of these cases, all have a fever and there is a history of closed contact to infected patients in the family within 3 days. These cases were hospitalized and had a complete recovery. Since the cases are early detected by screening of risk contact person to the known COVID‐19 cases, the patients did not show any serious lung abnormality, no lung infiltration from chest computed tomography (CT).[^3^](#ppul24737-bib-0003){ref-type="ref"} Indeed, different clinical features and chest CT findings are observed in COVID‐patients at different stages. The early diagnosis of pediatric COVID‐19 in our setting might result in mild clinical presentation.
